Brought to you by:
PAD: Endologix acquires PQ Bypass
Endologix recently announced completing the acquisition of PQ Bypass, a medical technology company pioneering a first-of-its-kind technology that addresses severe peripheral arterial disease (PAD). PQ Bypass’ proprietary Detour platform for percutaneous femoropopliteal bypass has been designated by the Food and…
Lessons in PAD care from VA vascular surgeons
The care of patients with peripheral arterial disease (PAD) is challenging and costly. Every practicing vascular surgeon knows that when patients present with ulcerations, infection, ischemia and comorbidities, we can accomplish amazing things. In an ideal world, our approaches universally…
Surmodics announces first patient uses of two Sublime radial access platform devices
Surmodics recently announced the successful first uses in patients for two devices within its Sublime radial access platform: the Sublime radial access guide sheath and Sublime radial access .014 RX percutaneous transluminal angioplasty (PTA) dilatation catheter. Constantino Pena, MD, Andrew Niekamp,…
Study identifies ‘critical need’ for guidelines on appropriate use of atherectomy
No data currently exist to support the use of atherectomy over other procedures for the treatment of peripheral arterial disease (PAD), and the healthcare expenditure associated with the procedure is substantial, write Caitlin W. Hicks MD, assistant professor of surgery at John…
SVS SET: PAD patient walks away from pain
Ice, cold and snow make it tough to walk outside in Lansing, Michigan, right now. So, jokes Doug Giller, he is wearing a path in his carpeting instead. For 45 minutes each evening, he walks a path throughout his house…
Coaches ‘integral’ to SVS SET app program
“A good coach will make his players see what they can be rather than what they are.” Those are words ascribed to football coach Ara Parseghian, who guided the University of Notre Dame to two national championships in the 1960s…
Supervised Exercise Therapy: There’s an app for that
Call it timing on several fronts, each part coming together for the benefit of patients with peripheral arterial disease (PAD). Included in the mix was an interest on the part of the Society for Vascular Surgery (SVS) to utilize technology…
Postmarket study of sirolimus-eluting balloon enrolls first patient
MedAlliance has announced enrollment of the first patient in SUCCESS PTA, its large post-market study with the drug-eluting balloon Selution SLR for the treatment of patients with peripheral arterial disease (PAD). Selution SLR is a novel sirolimus-eluting balloon that provides…
Veterans study: No evidence of increased risk of death with use of PCDs out to three years
A study of more than 10,000 U.S. veterans with peripheral arterial disease (PAD) undergoing endovascular interventions in the femoropopliteal segment found that rates of two‐ and three‐year all‐cause mortality were similar among patients undergoing revascularization with a paclitaxel-coated device (PCD)…
How to succeed in vascular surgery: A guide for the aspiring outlier
Disclaimer: The views expressed here do not reflect those of Mayo Clinic, the Society for Vascular Surgery, Vascular Specialist, or even the author, for that matter. It’s satirical—everybody relax. Our recent paper, “Practice patterns of vascular surgery’s ‘1%’” created a…